Understanding Germany's Healthcare System: Bismarck's Model Explained

German sickness funds have increasingly contracted for preferred drugs in exchange for rebates, extending from generics to branded drugs in classes with multiple competing brands. Funds negotiate discounts and establish preferred brands, driving higher uptake and pushing net prices below negotiated prices. A proposed 2016 rule would apply negotiated prices retrospectively to drugs exceeding €250 million in first-year sales, with payers clawing back differences. While not passed into law, payers indicated support for a lower €50 million threshold that would expose more drugs to price adjustment. This represents a shift toward managed entry agreements and price-volume arrangements.

This comprehensive webinar covers GKV and DGUV fee negotiations for 2024. The GKV achieved a 6.44% fee increase, exceeding the 2.6% inflation rate and negotiated without arbitration. The DGUV secured a 6.5% increase with automatic linkage to GKV changes. Key billing procedures include: fee splitting for prescriptions crossing year boundaries, first treatment day determining applicable fees, 14-day scheduling window for treatment start dates, 6-month long-term prescription validity, and trust protection for using old prescription forms. Children can consent to treatment from age 10. These negotiations aim to improve physiotherapy profession attractiveness and address healthcare workforce challenges.

In Germany, the largest EU market, the federal joint committee (a non-state self-governance body including payer representatives, healthcare professionals, and patient representatives) reviews new drugs. The Institute for Quality and Efficiency in Health Care compares new therapies against standard care (not placebo) and determines coverage based on holistic evidence including morbidity, mortality, quality of life, and patient experience. If a drug shows no added benefit, it cannot cost more than the current standard treatment; if it proves effective, negotiations occur with statutory health insurance companies to establish fair prices.

Das Hauptproblem der deutschen Gesundheitsversicherung liegt auf der Ausgabenseite, wobei die Finanzierungskrise durch ineffiziente Strukturen, Über- und Fehlversorgung sowie hohe Arzneimittelpreise verursacht wird; die Lösung erfordert Maßnahmen wie die Konzentration von Krankenhausleistungen auf spezialisierte Standorte, eine Notfallreform und Steigerung der Herstellerkennzahlen für patentierte Medikamente, anstatt Leistungskürzungen bei Beitragszahlern.

Germany has established a comprehensive pharmaceutical reimbursement system comprising Rabattverträge (discount agreements), Festbetragssystem (fixed price system), and frühe Nutzenbewertung (early benefit assessment). This system ensures patient access to innovative medications at sustainable prices while maintaining financial stability of statutory health insurance, achieving approximately 20 billion euros in savings over four years. The Pharmadialog process facilitated collaboration between government, industry, and stakeholders. The legislative debate revealed fundamental tensions between pharmaceutical industry interests and patient/insurance fund priorities, with the opposition criticizing the legislation as a failure of the Pharmadialog process that merely postponed complex challenges rather than resolving them.

Modern societies face unprecedented demographic challenges: extremely low birth rates combined with historically high life expectancy create rapidly aging populations. These two factors together produce societies that are simultaneously losing population (due to low births) and becoming increasingly elderly (due to long lifespans). This demographic combination causes pension costs to grow geometrically, making pay-as-you-go systems fundamentally unsustainable.

Social security operates on a pay-as-you-go model where current workers fund current retirees, not accumulated savings. Demographic shifts are creating sustainability challenges: declining birth rates (from 10-15 children per family in 1940 to 1-2 today), urbanization, and rising child-rearing costs have reduced the working-age population. Combined with medical advances extending life expectancy, this creates an aging population with more retirees and fewer contributors. IBGE projections indicate the 19-55 age group will be similar in size to those 60+ by 2060, threatening social security sustainability.

Pay-as-you-go pension systems, where current workers fund current retirees' benefits, face fundamental sustainability challenges when birth rates fall below replacement level (around 2 children per woman). As the working-age population shrinks relative to retirees, the system requires either higher contributions, increased taxes, or government borrowing to maintain benefit levels. This demographic reality makes such systems inherently unstable without significant reform, as fewer workers must support more retirees, creating a structural imbalance that cannot be solved by productivity gains alone.

Pay-as-you-go pension systems face mathematical sustainability challenges. Spain currently has 2 workers per pensioner, projected to decline to nearly 1 due to demographic changes. This creates: (1) The system 'quiebra cada 5 años' (bankruptcy every 5 years); (2) Pensioners have no 'right' to pensions because contributions are immediately spent on current retirees; (3) Future pensioners will receive 50% or less of their pre-retirement income; (4) The solution requires individual savings and investment, not reliance on public pensions.

Social Security operates as a pay-as-you-go system where current workers fund current retirees—it doesn't function as a personal savings account. Demographic challenges exist because baby boomers are retiring while the workforce is smaller, though this will reverse as millennials enter. The 1983 reforms gradually raised full retirement age from 65 to 67, giving decades to adjust. Current FICA taxes of 15.3% tax only 83% of wages; raising the wage base to $250,000 would tax 90% of wages and solve much of the funding problem.

Healthcare payment reform addresses outpatient care and digital health technology evaluation. This includes evaluating outpatient data submission for chronic disease management, home-based continuous positive airway pressure therapy, and medical DX (digital transformation) evaluation criteria. The evaluation process considers the resource requirements and complexity of home-based care and digital health technologies, ensuring that reimbursement reflects the actual costs and quality of care provided.

Germany is implementing major digital and social reforms. Electronic health records will document all patient medical history, with citizens able to object before September implementation. A national emergency alert system will send audio and text warnings to all mobile phones for natural and human-made emergencies. New European data protection laws will regulate smart devices like smart TVs and refrigerators, giving consumers more control over personal data. Simultaneously, the social welfare system (Bürgergeld) will freeze benefits at 563 euros for adults and 357-471 euros for children, with stricter rules penalizing missed appointments through significant deductions.

German healthcare reform proposals include: higher patient co-payments for medications and hospital stays, mandatory second opinions for elective surgeries like knee and hip replacements, removal of homoeopathic treatments from insurance coverage, elimination of free spouse insurance for couples without children under 6, and reduction of sick pay from 70% to 65% of gross salary.

German Health Minister Nina Warken (CDU) has announced a healthcare reform that requires patients to first visit their general practitioner (Hausarzt) before seeing specialists. This is not a reduction in medical services but a restructuring of the system. The reform includes: (1) mandatory referral system where patients must go through their family doctor first, (2) guaranteed timely appointments, (3) potential fees for direct specialist visits without referral, (4) digital assessment of initial consultations (e.g., by phone), (5) expanded roles for pharmacies and nurses. The goal is to reduce hospital burden and improve outpatient care quality by better distributing workload among healthcare providers.

The German CDU government announced reforms to the healthcare system and health insurance. Key changes include: (1) Reduction in sick pay (Krankengeld) for German workers, (2) Cancellation of free spouse insurance coverage in most cases, with only limited exceptions, (3) Increase in medication co-payment from 5-10 euros to 7.50-15 euros. These reforms are presented as measures to reduce costs for the state, though the video frames them as negatively impacting German citizens.